{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:44:56Z","timestamp":1754163896226,"version":"3.41.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"DOI":"10.7759\/cureus.89136","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:22:32Z","timestamp":1753978952000},"source":"Crossref","is-referenced-by-count":0,"title":["Lipid Inflammatory Indices as Predictors of Major Adverse Cardiovascular Events and Mortality in Patients With Non-ST-Elevation Myocardial Infarction Treated With Dual Antiplatelet Therapy and Statins"],"prefix":"10.7759","author":[{"given":"Amir","family":"Be\u0107irovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emir","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minela","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emir","family":"Begagic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Admir","family":"Abdic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenana","family":"Ljuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemana","family":"Buljubasic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadina","family":"Ljuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik","family":"Kasapovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrema","family":"Mujaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80159","article-title":"The inflammatory burden in heart failure: a cohort study on potential biomarkers in heart failure with reduced and mildly reduced ejection fraction","volume":"17","author":"Be\u0107irovi\u0107 E","year":"2025","unstructured":"Be\u0107irovi\u0107 E, Be\u0107irovi\u0107 M, Ljuca K, et al.. The inflammatory burden in heart failure: a cohort study on potential biomarkers in heart failure with reduced and mildly reduced ejection fraction. Cureus. 2025, 17:e80159. 10.7759\/cureus.80159","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2580","article-title":"Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome","volume":"76","author":"Sheng J","year":"2021","unstructured":"Sheng J, Liu N, He F, Cheng C, Shen S, Sun Y. Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome. Clinics (Sao Paulo). 2021, 76:e2580. 10.6061\/clinics\/2021\/e2580","journal-title":"Clinics (Sao Paulo)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7507\/1001-5515.202303038","article-title":"The research status and development trends of brain-computer interfaces in medicine","volume":"40","author":"Chen Q","year":"2023","unstructured":"Chen Q, Yuan T, Zhang L, et al.. The research status and development trends of brain-computer interfaces in medicine. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023, 40:566-72. 10.7507\/1001-5515.202303038","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S413538","article-title":"Comparison of different systemic inflammatory markers in predicting clinical outcomes with syntax score in patients with non-ST segment elevation myocardial infarction: a retrospective study","volume":"16","author":"Li H","year":"2023","unstructured":"Li H, Meng S, Chen W, Lei X, Kong X, Zhu H. Comparison of different systemic inflammatory markers in predicting clinical outcomes with syntax score in patients with non-ST segment elevation myocardial infarction: a retrospective study. Int J Gen Med. 2023, 16:2595-607. 10.2147\/IJGM.S413538","journal-title":"Int J Gen Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2024.1391550","article-title":"Several inaccurate or erroneous conceptions and misleading propaganda about brain-computer interfaces","volume":"18","author":"Chen Y","year":"2024","unstructured":"Chen Y, Wang F, Li T, et al.. Several inaccurate or erroneous conceptions and misleading propaganda about brain-computer interfaces. Front Hum Neurosci. 2024, 18:1391550. 10.3389\/fnhum.2024.1391550","journal-title":"Front Hum Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1367919","article-title":"Immune-inflammatory biomarkers for the occurrence of MACE in patients with myocardial infarction with non-obstructive coronary arteries","volume":"11","author":"Zhou H","year":"2024","unstructured":"Zhou H, Li X, Wang W, et al.. Immune-inflammatory biomarkers for the occurrence of MACE in patients with myocardial infarction with non-obstructive coronary arteries. Front Cardiovasc Med. 2024, 11:1367919. 10.3389\/fcvm.2024.1367919","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202309_33783","article-title":"Systemic inflammation response index is associated MACE in patients with NSTEMI","volume":"27","author":"Ozilhan MO","year":"2023","unstructured":"Ozilhan MO, \u00c7akmak Karaaslan O, Acikgoz SK, Selcuk H, Selcuk MT, Maden O. Systemic inflammation response index is associated MACE in patients with NSTEMI. Eur Rev Med Pharmacol Sci. 2023, 27:8588-97. 10.26355\/eurrev_202309_33783","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2508294","article-title":"Pan-immune-inflammatory value is superior to other inflammatory indicators in predicting inpatient major adverse cardiovascular events and severe coronary artery stenosis after percutaneous coronary intervention in STEMI patients","volume":"25","author":"Yang L","year":"2024","unstructured":"Yang L, Guo J, Chen M, Wang Y, Li J, Zhang J. Pan-immune-inflammatory value is superior to other inflammatory indicators in predicting inpatient major adverse cardiovascular events and severe coronary artery stenosis after percutaneous coronary intervention in STEMI patients. Rev Cardiovasc Med. 2024, 25:294. 10.31083\/j.rcm2508294","journal-title":"Rev Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2023.9178","article-title":"Prognostic value of a decrease in mean platelet volume, platelet distribution width, and platelet-large cell ratio for major adverse cardiovascular events after myocardial infarction without ST-segment elevation: an observational study","volume":"23","author":"Be\u0107irovi\u0107 E","year":"2023","unstructured":"Be\u0107irovi\u0107 E, Ljuca K, Be\u0107irovi\u0107 M, Ljuca N, Bajri\u0107 M, Brki\u0107 A, Ljuca F. Prognostic value of a decrease in mean platelet volume, platelet distribution width, and platelet-large cell ratio for major adverse cardiovascular events after myocardial infarction without ST-segment elevation: an observational study. Biomol Biomed. 2023, 23:866-72. 10.17305\/bb.2023.9178","journal-title":"Biomol Biomed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2022.9.n2037","article-title":"Prognostic value of non-traditional lipid parameters: Castelli Risk Index I, Castelli Risk Index II, and triglycerides to high-density lipoprotein cholesterol ratio among patients with non-ST-segment elevation myocardial infarction during 1\u2011year follow-up","volume":"62","author":"Drwi\u0142a D","year":"2022","unstructured":"Drwi\u0142a D, Rostoff P, Nessler J, Konduracka E. Prognostic value of non-traditional lipid parameters: Castelli Risk Index I, Castelli Risk Index II, and triglycerides to high-density lipoprotein cholesterol ratio among patients with non-ST-segment elevation myocardial infarction during 1\u2011year follow-up. Kardiologiia. 2022, 62:60-6. 10.18087\/cardio.2022.9.n2037","journal-title":"Kardiologiia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86446","article-title":"Integration of hematologic and metabolic biomarkers for outcome prediction in acute coronary syndromes without ST elevation","volume":"17","author":"Becirovic E","year":"2025","unstructured":"Becirovic E, Becirovic M, Ljuca K, et al.. Integration of hematologic and metabolic biomarkers for outcome prediction in acute coronary syndromes without ST elevation. Cureus. 2025, 17:e86446. 10.7759\/cureus.86446","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.706852","article-title":"The neutrophil-to-lymphocyte ratio is an important indicator predicting in-hospital death in AMI patients","volume":"8","author":"Ji Z","year":"2021","unstructured":"Ji Z, Liu G, Guo J, et al.. The neutrophil-to-lymphocyte ratio is an important indicator predicting in-hospital death in AMI patients. Front Cardiovasc Med. 2021, 8:706852. 10.3389\/fcvm.2021.706852","journal-title":"Front Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02783-9","article-title":"The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study","volume":"24","author":"Zhao J","year":"2025","unstructured":"Zhao J, Li N, Li S, Dou J. The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study. Cardiovasc Diabetol. 2025, 24:218. 10.1186\/s12933-025-02783-9","journal-title":"Cardiovasc Diabetol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6891537","article-title":"The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome","volume":"2019","author":"Mao Q","year":"2019","unstructured":"Mao Q, Zhou D, Li Y, Wang Y, Xu SC, Zhao XH. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome. Dis Markers. 2019, 2019:6891537. 10.1155\/2019\/6891537","journal-title":"Dis Markers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02586-7","article-title":"Atherogenic index of plasma and triglyceride-glucose index mediate the association between stroke and all-cause mortality: insights from the lipid paradox","volume":"24","author":"Qian J","year":"2025","unstructured":"Qian J, Chi Q, Qian C, Fan X, Ding W, Wang T, Zhu L. Atherogenic index of plasma and triglyceride-glucose index mediate the association between stroke and all-cause mortality: insights from the lipid paradox. Lipids Health Dis. 2025, 24:173. 10.1186\/s12944-025-02586-7","journal-title":"Lipids Health Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1580298","article-title":"Lipoprotein(a) and its linear association with all-cause and cardiovascular mortality in patients with acute coronary syndrome","volume":"16","author":"Qin K","year":"2025","unstructured":"Qin K, Zhang T. Lipoprotein(a) and its linear association with all-cause and cardiovascular mortality in patients with acute coronary syndrome. Front Endocrinol (Lausanne). 2025, 16:1580298. 10.3389\/fendo.2025.1580298","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8191254","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study","volume":"2016","author":"Liu X","year":"2016","unstructured":"Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study. Mediators Inflamm. 2016, 2016:8191254. 10.1155\/2016\/8191254","journal-title":"Mediators Inflamm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera A","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022, 23:3636. 10.3390\/ijms23073636","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2022.11.2.147","article-title":"Prognostic value of baseline neutrophil-to-lymphocyte ratio combined with anemia in patients with ST-segment elevation myocardial infarction: a nationwide prospective cohort study","volume":"11","author":"Cho KH","year":"2022","unstructured":"Cho KH, Shin MH, Kim MC, et al.. Prognostic value of baseline neutrophil-to-lymphocyte ratio combined with anemia in patients with ST-segment elevation myocardial infarction: a nationwide prospective cohort study. J Lipid Atheroscler. 2022, 11:147-60. 10.12997\/jla.2022.11.2.147","journal-title":"J Lipid Atheroscler"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/life14080985","article-title":"The prognostic role of the neutrophil-to-lymphocytes ratio in the most frequent cardiovascular diseases: an update","volume":"14","author":"Gosav EM","year":"2024","unstructured":"Gosav EM, Tanase DM, Buliga-Finis ON, Rezu\u0219 II, Morariu PC, Floria M, Rezus C. The prognostic role of the neutrophil-to-lymphocytes ratio in the most frequent cardiovascular diseases: an update. Life (Basel). 2024, 14:985. 10.3390\/life14080985","journal-title":"Life (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2019.39.4.345","article-title":"The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases","volume":"39","author":"Gasparyan AY","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019, 39:345-57. 10.3343\/alm.2019.39.4.345","journal-title":"Ann Lab Med"},{"key":"ref22","article-title":"Systemic inflammatory response syndrome","author":"Baddam S","year":"2025","unstructured":"Baddam S, Burns B. Systemic inflammatory response syndrome. StatPearls [Internet. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(06)70935-7","article-title":"Non ST segment elevation acute coronary syndromes: a simplified risk-orientated algorithm","volume":"22","author":"Fitchett DH","year":"2006","unstructured":"Fitchett DH, Borgundvaag B, Cantor W, et al.. Non ST segment elevation acute coronary syndromes: a simplified risk-orientated algorithm. Can J Cardiol. 2006, 22:663-77. 10.1016\/s0828-282x(06)70935-7","journal-title":"Can J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018897","article-title":"Lipid management in patients presenting with acute coronary syndromes: a review","volume":"9","author":"Claessen BE","year":"2020","unstructured":"Claessen BE, Guedeney P, Gibson CM, Angiolillo DJ, Cao D, Lepor N, Mehran R. Lipid management in patients presenting with acute coronary syndromes: a review. J Am Heart Assoc. 2020, 9:e018897. 10.1161\/JAHA.120.018897","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395813-lipid-inflammatory-indices-as-predictors-of-major-adverse-cardiovascular-events-and-mortality-in-patients-with-non-st-elevation-myocardial-infarction-treated-with-dual-antiplatelet-therapy-and-statins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:22:34Z","timestamp":1753978954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395813-lipid-inflammatory-indices-as-predictors-of-major-adverse-cardiovascular-events-and-mortality-in-patients-with-non-st-elevation-myocardial-infarction-treated-with-dual-antiplatelet-therapy-and-statins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.89136","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}